Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

pexidartinib hydrochloride

(PEK-sih-DAR-tih-nib HY-droh-KLOR-ide)
A drug used to treat adults with tenosynovial giant cell tumor (a rare, usually benign tumor that affects the joints). It is used in patients who have a severe form of the disease that is not likely to get better with surgery. It is also being studied in the treatment of some types of cancer and other conditions. Pexidartinib hydrochloride blocks certain proteins, which may help keep tumor cells from growing and spreading. It is a type of tyrosine kinase inhibitor. Also called Turalio.
Search NCI's Dictionary of Cancer Terms